NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples